Recently, the Centers for Disease Control and Prevention (CDC) concluded live attenuated influenza vaccine (LAIV), also known as the nasal spray flu vaccine or FluMist, should not be used during the 2016–2017 flu season. The CDC recommendation was made after recent studies showed FluMist was not effective against the flu.

To ensure Drake Medical Plan participants receive the most effective preventive treatment during the upcoming flu season, Wellmark will no longer cover the nasal spray vaccine formulation, effective July 1, 2016. The injectable vaccine, however, will continue to be covered under the Drake Medical Plan.

Should you have questions regarding this change, please contact Wellmark at 800-362-2230.

—Marlene Heuertz, Associate Director, Benefits